Skip to content
10-Q

Quarterly Report

ImmunoGen, Inc.

0001558370-23-012564

← back to feed
Filed
Jul 31, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 25, 2023 248.94M sh
Capex Q2 2023 · Jun 30, 2023 $287K
Capex Q2 2023 · Jun 30, 2022 $514K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$140.46M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$105.39M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $571.99M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $275.14M
Stockholders Equity Q2 2023 · Jun 30, 2023 $490.84M
Stockholders Equity Q2 2023 · Mar 31, 2023 $121.92M
Stockholders Equity Q2 2023 · Dec 31, 2022 $155.83M
Stockholders Equity Q2 2023 · Sep 30, 2022 $178.01M
Stockholders Equity Q2 2023 · Jun 30, 2022 $249.83M
Stockholders Equity Q2 2023 · Mar 31, 2022 $306.47M
Stockholders Equity Q2 2023 · Dec 31, 2021 $325.59M
Current Liabilities Q2 2023 · Jun 30, 2023 $93.7M
Current Liabilities Q2 2023 · Dec 31, 2022 $121.86M
Total Liabilities Q2 2023 · Jun 30, 2023 $223.49M
Total Liabilities Q2 2023 · Dec 31, 2022 $193.11M
Current Assets Q2 2023 · Jun 30, 2023 $669.27M
Current Assets Q2 2023 · Dec 31, 2022 $304.12M
Total Assets Q2 2023 · Jun 30, 2023 $714.33M
Total Assets Q2 2023 · Dec 31, 2022 $348.94M
Eps Basic Q2 2023 · Jun 30, 2023 −$0.02
Eps Basic Q2 2023 · Jun 30, 2023 −$0.17
Eps Basic Q2 2023 · Jun 30, 2022 −$0.24
Eps Basic Q2 2023 · Jun 30, 2022 −$0.34
Sga Expense Q2 2023 · Jun 30, 2023 $36.36M
Sga Expense Q2 2023 · Jun 30, 2023 $76.37M
Sga Expense Q2 2023 · Jun 30, 2022 $23.79M
Sga Expense Q2 2023 · Jun 30, 2022 $40.44M
Rd Expense Q2 2023 · Jun 30, 2023 $50.08M
Rd Expense Q2 2023 · Jun 30, 2023 $101.7M
Rd Expense Q2 2023 · Jun 30, 2022 $51.42M
Rd Expense Q2 2023 · Jun 30, 2022 $95.7M
Net Income Q2 2023 · Jun 30, 2023 −$4.25M
Net Income Q2 2023 · Jun 30, 2023 −$45.26M
Net Income Q2 2023 · Mar 31, 2023 −$41.01M
Net Income Q2 2023 · Dec 31, 2022 −$59.01M
Net Income Q2 2023 · Sep 30, 2022 −$77.76M
Net Income Q2 2023 · Jun 30, 2022 −$62.02M
Net Income Q2 2023 · Jun 30, 2022 −$86.17M
Net Income Q2 2023 · Mar 31, 2022 −$24.15M
Operating Income Q2 2023 · Jun 30, 2023 −$4.19M
Operating Income Q2 2023 · Jun 30, 2023 −$46.58M
Operating Income Q2 2023 · Jun 30, 2022 −$61.05M
Operating Income Q2 2023 · Jun 30, 2022 −$83.91M
Shares Diluted Q2 2023 · Jun 30, 2022 253.26M sh
Shares Diluted Q2 2023 · Jun 30, 2021 199.37M sh
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.34
Eps Diluted Q2 2023 · Jun 30, 2021 −$0.32